Cochrane at the 79th World Health Assembly
Following a busy week at the 79th World Health Assembly (WHA), we’re reflecting on the inspiring conversations and high-level discussions Cochrane had the privilege of being involved in.
Right tool, right job: deciding when to not use an AI tool
From searching and screening to drafting text, artificial intelligence (AI) tools offer the promise of increased efficiency. But with promise comes responsibility. Ella Flemyng, Cochrane’s Head of Editorial Policy and Research Integrity, highlights what you need to consider when deciding whether to use an AI tool, and when you might decide not to.
We are looking for a new author team to update a key review on over-the-counter medicines for acute cough. The Cochrane review incorporates evidence from 1966 up to 2012 and a new search for recently published evidence is necessary. Take a look at the requirements, the support we can offer and information on how to register your interest.
Cochrane strengthens systems to manage retracted publications in its published reviews
As part of our commitment to the highest standards of evidence, Cochrane is strengthening how it identifies and manages retracted publications associated with studies included in published or ongoing Cochrane reviews. This includes new steps to manage retractions of included studies that occur after reviews have been published.
Making our evidence more usable – interoperability in practice
Cochrane has always aimed to provide the right evidence at the right time. As we move into a more collaborative and AI-enabled era, delivering this goal will increasingly rely on structured data. Gert van Valkenhoef, Cochrane’s Head of Data, sets out why we are improving Cochrane’s approach to data, the difference this could make, and what this means for our authors.
Breast cancer risk models fall short for women with family history
Researchers from Trinity College Dublin, St James’s Hospital, and collaborating institutions have carried out the most comprehensive review to date of tools used to estimate breast cancer risk in women with a family history of the disease.
Early birth safer for mother and baby in high blood pressure pregnancies
Planned early birth for pregnant women with high blood pressure cuts maternal complications by nearly half and reduces the risk of stillbirth, without increasing the likelihood of caesarean section, according to a new Cochrane review.
From evidence to impact: how Cochrane Thailand is turning research into practice
Discover the role Cochrane Thailand has played in closing the gap between evidence and outcomes. Designated as a WHO Collaborating Centre for Research Synthesis in Reproductive Health, the group has not only generated Cochrane reviews but has also translated those findings into national policy and clinical guidelines.
Screening modestly reduces prostate cancer deaths
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review.
What makes Cochrane’s new AI study innovative?
Cochrane has released a pre-print of the protocol for our innovative study that will test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. Gerald Gartlehner from Cochrane Austria, Principal Investigator for the study, discusses how the study works, and what makes it interesting.
News
News
Trusted evidence.
Informed decisions.
Better health.
Informed decisions.
Better health.
11-13 Cavendish Square
London
W1G 0AN
United Kingdom
The Cochrane Collaboration is a charity (no. 1045921) and a company limited by guarantee (no. 03044323) registered in England & Wales. VAT registration number GB 718 2127 49.
Copyright © 2026 The Cochrane Collaboration